NSW (9739) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
9 Nov, 2026Executive summary
H1 FY2027 net sales rose 2.6% YoY to ¥25,493m, while operating profit fell 1.9% to ¥2,315m and profit attributable to owners fell 6.7% to ¥1,554m.
Net assets increased to ¥38,186m at Sep. 30, 2026, from ¥37,891m at Mar. 31, 2026; equity-to-asset ratio was 78.7%, up from 76.9%.
Financial highlights
Gross profit was ¥4,950m versus ¥5,039m YoY; SG&A declined to ¥2,634m from ¥2,678m.
Ordinary profit declined 5.9% YoY to ¥2,287m; profit before income taxes was ¥2,286m versus ¥2,418m.
Comprehensive income was ¥1,561m, down from ¥1,658m YoY.
Outlook and guidance
FY2027 forecasts: net sales ¥54,000m (+3.0% YoY), operating profit ¥5,400m (+2.1%), ordinary profit ¥5,450m, and profit attributable to owners ¥3,750m (+1.5%).
FY2027 forecast basic EPS is ¥251.69; the financial-results forecast was unchanged from the latest announcement.
FY2027 forecast annual dividend is ¥125 per share; the second-quarter dividend is ¥60, with no revision to the dividend forecast.
Latest events from NSW
- Sales rose 4.4% year-over-year, but profits dipped; full-year growth and dividends are forecast.9739
Q1 2027 - Net sales up 4.8% YoY, operating profit down 13.5%, dividend per share raised to ¥125.00.9739
Q4 2026 - Sales grew, but profits fell on higher costs and one-time losses; lower profit forecast ahead.9739
Q3 2026 - Sales rose, but profits fell on higher costs; full-year outlook projects lower earnings.9739
Q2 2026 - Quarterly profits and comprehensive income rose, with moderate growth forecast for the full year.9739
Q1 2025 - Sales and profit rose modestly, with strong capital and higher cash reserves.9739
Q2 2025 - Sales and profits rose, with strong capital and cash; full-year profit to dip slightly.9739
Q3 2025 - Profit fell despite stable sales, with lower EPS and a cautious outlook for next year.9739
Q4 2025 - Sales rose 4.2% year-over-year, but profits and net income declined; outlook remains cautious.9739
Q1 2026